We Are One Seven LLC Has $784,000 Stock Holdings in Cooper Companies Inc (NYSE:COO)

We Are One Seven LLC raised its stake in Cooper Companies Inc (NYSE:COO) by 2.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,328 shares of the medical device company’s stock after acquiring an additional 63 shares during the period. We Are One Seven LLC’s holdings in Cooper Companies were worth $784,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Evolution Wealth Advisors LLC acquired a new position in Cooper Companies in the 2nd quarter valued at $34,000. Quadrant Capital Group LLC increased its stake in shares of Cooper Companies by 827.8% in the 1st quarter. Quadrant Capital Group LLC now owns 167 shares of the medical device company’s stock valued at $47,000 after purchasing an additional 149 shares during the last quarter. Zions Bancorporation N.A. bought a new position in shares of Cooper Companies in the 1st quarter valued at $53,000. CNB Bank bought a new position in shares of Cooper Companies in the 1st quarter valued at $59,000. Finally, Thor Advisors LLC bought a new position in shares of Cooper Companies in the 1st quarter valued at $69,000. 96.86% of the stock is owned by hedge funds and other institutional investors.

COO has been the topic of several recent analyst reports. Zacks Investment Research lowered Home Bancshares from a “hold” rating to a “sell” rating in a research note on Friday, June 7th. Wells Fargo & Co reiterated a “buy” rating on shares of Allergan in a research note on Monday, June 10th. Northcoast Research reiterated a “buy” rating and issued a $340.00 price target (up previously from $331.00) on shares of Cooper Companies in a research note on Monday, June 3rd. Finally, Raymond James reiterated a “buy” rating and issued a $26.00 price target on shares of Propetro in a research note on Tuesday, July 2nd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $318.91.

In other Cooper Companies news, Director Gary S. Petersmeyer sold 355 shares of Cooper Companies stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $323.92, for a total transaction of $114,991.60. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Randal Golden sold 1,154 shares of Cooper Companies stock in a transaction dated Wednesday, June 19th. The stock was sold at an average price of $328.16, for a total value of $378,696.64. Following the transaction, the vice president now directly owns 1,148 shares in the company, valued at $376,727.68. The disclosure for this sale can be found here. Insiders have sold a total of 77,678 shares of company stock worth $25,063,536 in the last 90 days. 1.70% of the stock is currently owned by corporate insiders.

COO stock traded down $0.88 during midday trading on Tuesday, reaching $340.61. 3,641 shares of the stock were exchanged, compared to its average volume of 245,328. The company has a market cap of $16.89 billion, a PE ratio of 29.60, a PEG ratio of 2.56 and a beta of 0.84. Cooper Companies Inc has a 52 week low of $228.65 and a 52 week high of $343.33. The company has a quick ratio of 0.68, a current ratio of 1.21 and a debt-to-equity ratio of 0.42. The firm has a fifty day moving average of $331.14.

Cooper Companies (NYSE:COO) last issued its quarterly earnings data on Thursday, May 30th. The medical device company reported $2.94 earnings per share for the quarter, topping analysts’ consensus estimates of $2.76 by $0.18. The business had revenue of $654.30 million for the quarter, compared to analyst estimates of $655.00 million. Cooper Companies had a return on equity of 17.25% and a net margin of 16.46%. Cooper Companies’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.86 EPS. As a group, sell-side analysts expect that Cooper Companies Inc will post 12.27 EPS for the current year.

The company also recently disclosed a Semi-Annual dividend, which will be paid on Wednesday, August 7th. Investors of record on Tuesday, July 23rd will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Monday, July 22nd. Cooper Companies’s dividend payout ratio is currently 0.52%.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

See Also: What is the Consumer Price Index (CPI)?

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.